Subject: Molecular Psychiatry - Table of Contents alert Volume 11 Issue 9

From: "MolecularPsychiatryAlert"<[email-masked]>
Date: Mon, 28 Aug 2006 07:21:20 -0400 (EDT)

| | Accessibility statement Jump to content
| NATURE.COM [email-masked] NATUREJOBS NATUREEVENTS ABOUT NPG

MY ACCOUNT|E-ALERTS|SUBSCRIBE|REGISTER

TABLE OF CONTENTS

| |

Volume 11, Issue 9 (September 2006)
Image
Letters to the Editor
Feature Reviews
Original Articles

Recommend to your library

With an impact factor of 9.335*, Molecular Psychiatry is the #2 journal in psychiatry!* If you can't access the articles below, let your librarian know that you would like full-text access from your desktop.
*Journal Citation Reports, Thomson, 2006.

Image

Top

COMT haplotype variation affects human prefrontal function

A Meyer-Lindenberg, T Nichols, J H Callicott, J Ding, B Kolachana, J Buckholtz, V S Mattay, M Egan and D R Weinberger

Mol Psychiatry 2006 11: 797; 10.1038/sj.mp.4001881

Abstract | Full Text

Letters to the Editor

Top

Evidence that a DISC1 frame-shift deletion associated with psychosis in a single family may not be a pathogenic mutation

E K Green, N Norton, T Peirce, D Grozeva, G Kirov, M J Owen, M C O'Donovan and N Craddock

Mol Psychiatry 2006 11: 798-799; 10.1038/sj.mp.4001853

Abstract | Full Text

Genotyping of the G1463A (Arg441His) TPH2 polymorphism in a geriatric population of patients with major depression

M A Bicalho, G J Pimenta, F S Neves, H Correa, E N de Moraes, L De Marco and M A Romano-Silva

Mol Psychiatry 2006 11: 799-800; 10.1038/sj.mp.4001861

Abstract | Full Text

Reduced brain leptin in patients with major depressive disorder and in suicide victims

N Eikelis, M Esler, D Barton, T Dawood, G Wiesner and G Lambert

Mol Psychiatry 2006 11: 800-801; 10.1038/sj.mp.4001862

Abstract | Full Text

Functional SLITRK1 var321, varCDfs and SLC6A4 G56A variants and susceptibility to obsessive-compulsive disorder

J R Wendland, M R Kruse and D L Murphy

Mol Psychiatry 2006 11: 802-804; 10.1038/sj.mp.4001848

Abstract | Full Text

Feature Reviews

Top

Treatment-resistant anxiety disorders

A Bystritsky

Mol Psychiatry 2006 11: 805-814; advance online publication, July 18, 2006; 10.1038/sj.mp.4001852

Abstract | Full Text

Subtyping schizophrenia: implications for genetic research

A Jablensky

Mol Psychiatry 2006 11: 815-836; advance online publication, June 27, 2006; 10.1038/sj.mp.4001857

Abstract | Full Text

Original Articles

Top

Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase II gene (PIP5K2A) with schizophrenia

S G Schwab, M Knapp, P Sklar, G N Eckstein, C Sewekow, M Borrmann-Hassenbach, M Albus, T Becker, J F Hallmayer, B Lerer, W Maier and D B Wildenauer

Mol Psychiatry 2006 11: 837-846; advance online publication, June 27, 2006; 10.1038/sj.mp.4001864

Abstract | Full Text

Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder

B S Pickard, M P Malloy, A Christoforou, P A Thomson, K L Evans, S W Morris, M Hampson, D J Porteous, D H R Blackwood and W J Muir

Mol Psychiatry 2006 11: 847-857; advance online publication, July 4, 2006; 10.1038/sj.mp.4001867

Abstract | Full Text

A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index

F Ducci, T K Newman, S Funt, G L Brown, M Virkkunen and D Goldman

Mol Psychiatry 2006 11: 858-866; advance online publication, June 13, 2006; 10.1038/sj.mp.4001856

Abstract | Full Text

Impact of complex genetic variation in COMT on human brain function

A Meyer-Lindenberg, T Nichols, J H Callicott, J Ding, B Kolachana, J Buckholtz, V S Mattay, M Egan and D R Weinberger

Mol Psychiatry 2006 11: 867-877; advance online publication, June 20, 2006; 10.1038/sj.mp.4001860

Abstract | Full Text

The SNAP-25 gene is associated with cognitive ability: evidence from a family-based study in two independent Dutch cohorts

M F Gosso, E J C de Geus, M J van Belzen, T J C Polderman, P Heutink, D I Boomsma and D Posthuma

Mol Psychiatry 2006 11: 878-886; advance online publication, June 27, 2006; 10.1038/sj.mp.4001868

Abstract | Full Text

Why publish in Molecular Psychiatry?
Over 97,000 recipients will receive via e-mail a copy of the table of contents for the Molecular Psychiatry issue in which your article is published.
There are an average of 85,000 page views across the Molecular Psychiatry web site per month.
The journal’s current Impact Factor is 9.335 (Thomson, 2006)
Learn more about the benefits of publishing your paper in the journal.

| |
| | | | | |

| |

| |
| |

More Nature Products

More Nature Events

| |

ADVERTISEMENT

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

© 2006 Nature Publishing Group